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Abstract
Background: Patients with severe mental disorders have a higher 
prevalence of cardiovascular risk factors. Obesity and sedentarism are 
cardiovascular risk factors and their control reduces morbidity and 
mortality. Thus, interventions directed toward decreasing weight and/
or increasing the level of physical activity are necessary.
Objectives: The aim of this study would be to evaluate the effec-
tiveness of an educational intervention focused on diet and physical 
activity in order to change the amount of physical activity, Body Mass 
Index and waist circumference in these patients.
Design: Randomized clinical trial with a control group with one-year 
follow-up.
Setting: Outpatient Mental Health Teams of Barcelona and a resi-
dence for patients with severe mental disorders.
Participants: Patients between 18 and 65 years of age diagnosed 
with schizophrenia, a schizoaffective disorder or bipolar disorder in 
treatment with antipsychotic medication and a low level of physical 
activity (240 patients in each randomized group).
The Effectiveness of a Program of Physical Activity 
and Diet to Modify Cardiovascular Risk Factors in 
Patients with Severe Mental Illness (CAPiCOR Study)
 STUDY PROTOCOL 
Roser Masa Font1, Maria Isabel Fernández Sanmartín2, 
Luis Miguel Martín López3, Noemí Olona Tabueña4, 
Sílvia Oller Canet5, Luisa San Emeterio Echevarría6, 
Montserrat Ibarra Jato7, Belén Díaz Múgjica8, 
Susana González Tejón9, Lidia Viñas Cabrera10, Celia Tajada Vitales11, 
Antonio Manuel Alba Muñoz12, Rosa Sanchís Catalán8, 
Albert Barroso García13, Jaume Martín Royo14, 
Teresa Salvador Barbarroja6
1  EAP Besòs, Institut Català de la Salut (ICS), 
Barcelona, Spain; Universitat Autònoma de 
Barcelona, Bellaterra, Spain.
2  Unitat Docent de Medicina Familiar i 
Comunitària, Barcelona, Spain.
3  Centre Institut de Neuropsiquiatria i 
Addiccions (INAD). Barcelona, Spain.
4  Àmbit d'Atenció Primària Barcelona Ciutat. 
Unitat d'Avaluació, Sistemes d'Informació i 
Qualitat, Barcelona, Spain.
5  Centre Salut Mental Maragall (INAD), 
Barcelona, Spain.
6  Centre Salut Mental Sant Martí Nord (INAD), 
Barcelona, Spain.
7  Centre Salut Mental Martí i Julià (INAD), 
Santa Coloma de Gramenet, Spain.
8  Centre Salut Mental Sant Martí Sud (INAD), 
Barcelona, Spain.
9  EAP Raval Sud (ICS), Barcelona, Spain
10  EAP Poblenou (ICS), Barcelona, Spain.
11  EAP Doctor Vilaseca (Can Mariner), Santa 
Coloma de Gramenet, Spain.
12  Centre Salut Mental Ciutat Vella, Parc 
Sanitari Sant Joan de Déu, Barcelona, Spain.
13  EAP Sant Martí (ICS), Barcelona, Spain.
14  CUAP Casernes (ICS), Barcelona, Spain.
Contact information:
Roser Masa Font.
Address: EAP Besòs, Institut Català de 
la Salut (ICS), C/Alfons el Magnànim, 57, 
08019, Barcelona, Spain.
Tel: (34) 605579099
 rosermasa@gmail.com
InternatIonal archIves of MedIcIne
sectIon: PsychIatry & Mental health
ISSN: 1755-7682 
2015
Vol. 8 No. 97
doi: 10.3823/1696
This article is available at: www.intarchmed.com and www.medbrary.com 2
Background
Schizophrenia, schizoaffective and bipolar disorders 
included in the group of severe mental disorders 
[SMD] have an overall prevalence of 3% in the ge-
neral population [1].
Despite being a predominantly young popula-
tion, in comparison to the general population, the-
se patients have a significantly higher presence of 
cardiovascular risk factors [CVRF] such as smoking, 
obesity, dyslipidemia, diabetes mellitus or metabolic 
syndrome [MS] [2, 3] along with a decrease in life 
expectancy of between 10 and 25 years [4]. 
This increased risk is due to the interaction of 
multiple etiological factors [5]: Genetic predispo-
sition [6], environmental factors due to unhealthy 
lifestyles (bad dietary habits, smoking and seden-
tarism) [7] and the increasingly evident contribution 
of antipsychotic drugs in metabolism disorders, es-
pecially clozapine and olanzapine [8]. 
Obesity and sedentarism are independent 
CVRF. Their role in terms of cardiovascular risks 
has been well documented (Framingham Heart 
Study) [9]. However, they are also associated with 
many other diseases (osteoarthritis, cholelithia-
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Intervention group: Physical activity group educational program 
of 24 sessions over 12 weeks and diet (16 sessions in the first 8 
weeks) carried out by nurses and physical activity specialists. 
Control group: Usual practice with regular checks and the usual 
treatment of their disease.
Main outcome measures: Level of physical activity (IPAQ ques-
tionnaire), weight, Body Mass Index and waist circumference.
Other outcomes: Cardiovascular risk, quality of life (SF-36 ques-
tionnaire), tobacco consumption, dietary habit (PREDIMED question-
naire), blood pressure and laboratory parameters (cholesterol, trigly-
cerides, glucose).
Evaluations will be masked and will be made at 0, 3, 6 and 12 months. 
Data analysis: Intention to treat analysis. Analysis of variance for 
repeated measures to adjust for differences attributable to the effect 
of the intervention for potential confounders (drug treatment, care 
level of intervention and mental status of the patient).
Ethical aspects: The project has been evaluated and approved 
by the ethics committee (CEIC) of the Primary Healthcare-University 
Research Institute IDIAP Jordi Gol, with registration number P11/64.
Trial registration: Clinicaltrials.gov NCT01729650.
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sis, cancer, hepatic steatosis, peripheral vascular 
disease, psychological disorders and decreased 
quality of life, etc.). The most accepted method 
to define and classify obesity is the Body Mass 
Index [BMI] [10]. However, determining the waist 
circumference [WC] or abdomen circumference is 
also important as the risks associated with obesity 
not only depend on total adiposity, but its distri-
bution (android), other CVRF and other comorbi-
dities as well [5]. Obesity and overweight are two 
to three times more prevalent in patients with 
psychotic disorders. It is mostly due to abdominal 
type obesity [3, 11]. 
Interventions that have proven effective have 
been carried out to decrease the cardiovascular 
risk of patients with psychosis. A systematic re-
view of 2010 that collected 21 randomized cli-
nical trials of interventions to reduce or give up 
smoking in schizophrenia patients concluded that 
bupropion is able to bring about a reduction in 
the consumption of tobacco when compared to 
a placebo [12].
Other reviews of interventions aimed at reducing 
body weight or increasing the level of physical ac-
tivity [PA] are less conclusive because of the small 
number of studies included, the small sample size 
or the heterogeneity of the variables collected. In a 
2007 review by Cochrane [13], three randomized cli-
nical trials were included but they had small sample 
sizes and short follow-ups. In another review that 
included 15 clinical trials, the outcome variables are 
highly heterogeneous [14]. Then again, in a review 
from 2012 with studies using similar response varia-
bles, sample sizes are very small [15]. Nevertheless, 
all these reviews suggested a benefit from these 
interventions.
Wu evaluated the effect of diet monitoring and 
exercise in obese patients with schizophrenia trea-
ted with olanzapine (n=53) in which an improve-
ment in metabolic profile and significant decrease in 
weight, BMI and WC was seen [16]. Daumit recently 
conducted an intervention in almost 300 patients 
with a severe mental disorder which revealed a sig-
nificant decrease in weight at 18 months in the 
intervention group [17]. Moreover, Fernandez has 
presented the results of a meta-analysis that inclu-
des 20 studies which demonstrated that interven-
tions to modify lifestyles improve anthropometric 
and clinical parameters at 3 months. At 6 and 12 
months, the difference between the control and in-
tervention groups is maintained, although with less 
precision [18].
Weight reduction and the practice of regular PA 
are possible in patients with psychosis and they 
improve their perception of health [3]. However, 
more research is needed with larger samples of 
subjects. 
Interdisciplinary work is critical to approaching 
these disorders and the interventions. The joint work 
of the Primary Care Team [PCT] and Mental Health 
Team [MHT] is essential to developing physical care 
activities and health promotion as well as impro-
ving the care process of patients with psychosis. 
The early detection of CVRF and early symptoms, 
prioritized referral to primary care and promoting 
compliance and adherence are also relevant [19]. 
For this reason, the recommendations in the lite-
rature contemplate improving monitoring of CVRF 
in these patients and establishing channels of close 
collaboration between psychiatrists and the PCT as 
aims [20, 21].
Our group initiated a collaborative study between 
seven PCT and three reference MHT outpatient 
centers from which a joint protocol for monitoring 
CVRF emerged [22]. 
The outcome of this interest in improving the phy-
sical health of patients with psychosis is the present 
study. Its main objective is to evaluate the effective-
ness of an intervention based on a program of PA 
and diet. It is a program coordinated between PCT 
and MHT to change the level of weekly PA, BMI and 
WC in patients with schizophrenia, schizoaffective 
or bipolar disorders.
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Secondary objectives will evaluate the effective-
ness of this intervention to modify the cardiovascu-
lar risks, quality of life, tobacco consumption, die-
tary habits, blood pressure and plasma cholesterol 
and blood sugar levels.
Methods/design
Study design
Randomized clinical trial with a control group with 
one-year follow-up. Response variables will be as-
sessed at 3, 6 and 12 months in comparison to ba-
seline measurements (month 0) in the intervention 
group [IG] and control group [CG] (Figure 1).
Setting 
Six public mental health centers and a residential 
center, all located in the metropolitan area of Bar-
celona, participated. These centers serve patients 
referred by the corresponding PCT on an outpatient 
basis. 
Participants - Study Population 
Population residing to the geographical reference 
area of the MHT in Barcelona (281,706) and Santa 
Coloma (131,917), with the following selection cri-
teria will be included:
Inclusion criteria
-  Patients between 18 and 65 years of age with 
an antipsychotic drug treatment for at least 3 
months prior to enrollment.
-  Diagnosis recorded in the medical history: schi-
zophrenia disorders (F20.* of ICD10), schizoa-
ffective disorders (F25.* of ICD10) Bipolar disor-
der (F31.* of ICD10) and confirmed by their doc-
tor through a clinical interview (DSM_IV criteria)
Figure 1: General flow of the design, number of patients and measurements taken in the follow-up
Intervention Group
n=167
30% follow-up 
losses
30% follow-up 
losses
Control Group
n=167
Physical Activity
-  4 weeks group PA in the health 
center
-  2 sessions of 1 hour/week
-  8 weeks PA walking outside of 
center
-  2 sessions of 1 hour/week
Diet
-  8 weeks 
-  1 session of 40 minutes/week
Initial Evaluation
3 mth. Evaluation
6 mth. Evaluation
1 yr. Evaluation
Intervention Group
n=239
Control Group
n=239
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-  Residing in the reference area (area of influence 
of the MHT and PCT participants) for a mini-
mum of one year.
- Knowledge of the Spanish language.
-  Low level of PA (short version of the ques-
tionnaire, International Physical Activity Ques-
tionnaire, IPAQ). It means patients who do 
not perform moderate / high PA: 3 or more 
days of vigorous activity such as construction 
work, aerobics, cycling fast pace (requires 
hard physical effort and makes you breathe 
much harder than normal); or 5 or more days 
of moderate activity like carrying low weight, 
cycling at a steady pace (moderate physical 
effort and makes you breathe harder than 
normal). [23]
-  BMI values equal or greater than 25, so it in-
cludes patients with overweight (25-29,9) and 
obesity (>30) [10]. 
Exclusion criteria
-  Patients that present any contraindication (phy-
sical illness) for PA [24]
- Pregnancy or breastfeeding
-  Having suffered an episode of acute mania or 
psychotic state one month before enrollment.
-  Decompensation of the psychotic pathology 
from one month prior up to the time of re-
cruitment measured by means of the Clinical 
Global Impression Scale [25] 
-  Dependence for substance abuse according to 
DSM-IV criteria with active consumption, except 
for nicotine dependence.
-  Not visited by the MHT or by the PCT in the 
year prior to inclusion in the study
Recruitment
Selection will be made consecutively. The professio-
nals from the MHT will recruit from among those 
visited in their centers. The recruitment period will 
be for about 6-12 months, taking advantage of the 
visits scheduled with the MHT or visits with the PCT. 
The assessment of inclusion/exclusion will be made 
by the patient's psychiatrist.
Sample size
The sample size for each of the main measure-
ments has been calculated and the one resulting 
in a larger sample size (BMI) has been chosen. 
Accepting an alpha risk of 0.05 and a beta risk 
of 0.20 in a bilateral contrast, it is necessary to 
study 478 subjects (239 subjects in the IG and 
239 in the CG) to detect a difference equal to 
or greater than 1.9 kg/m2 in the BMI [26]. It is 
assumed that the common standard deviation is 
6.2. A loss rate of 30% at follow-up has been 
estimated. It was decided to calculate the sam-
ple size using the BMI because we found quite a 
bit of literature in which this measure was used. 
However, we had no reference values in the IPAQ 
(the questionnaire used to assess physical activi-
ty) for SMD patients.
Randomization
After confirming that the criteria for inclusion has 
been met through the initial interview and once 
informed consent is signed, the distribution will be 
made at random by a computer program run by 
an outside researcher foreign to the professional 
recruiters to generate random numbers. They will 
be distributed so that in each center, half of the 
patients make up the IG patients and the other half 
make up the CG.
Blinding
Random assignment and collection of information 
will be carried out blind. During follow-up inter-
views the interviewer will advise the patient not to 
disclose whether the intervention has been done 
or not. Regardless, the percentage of patients who 
unmask the group to which they belong during the 
evaluation will be checked.
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Materials Involved 
For measurements of physical variables, stadiome-
ters, scales, tape measures, sleeves and blood pres-
sure apparatus and other equipment necessary to 
perform the analysis will be used. The equipment 
is calibrated annually.
For the interventions, brochures with dietary and 
physical activity recommended, a food intake diary, 
notebooks, pens and pedometers will be handed 
out.
Intervention design 
The subjects assigned to the CG will follow the usual 
practice with regular checks with their psychiatrist 
reference (usually every two months, if no decom-
pensation) and the usual treatment of their disease. 
Patients in both groups will be assigned the in-
tervention protocol set that the team participating 
in the project elaborated [22]. Thus, patients with 
above normal parameters will be sent to their doc-
tor to start a treatment plan.
The IG subjects will go through an educational 
program and carry out a PA program based on di-
fferent stages as well as a dietary intervention in 
groups. 
All the professional participants will receive trai-
ning beforehand. The evaluators will undergo prior 
training by the research team (consisting of nurses, 
psychiatrists, family doctors and health technicians) 
about scales, physical measurements and the accu-
rate collection of data.
Manuals on diet and PA have also been deve-
loped to facilitate the training of the professionals 
who will carry out the interventions.
Physical Activity Intervention
The frequency of the sessions will be 2 times a week 
with a duration of between 40 and 60 minutes 
each. The number of people per group will be a 
maximum of 15 people.
1. Familiarization phase (4 weeks, 40-minute ses-
sions). Making contact with PA (intensity, recom-
mendations for safe practices, etc...), pedometers 
and professionals bolster the program (MHT Nur-
sing). The sessions will be held in the rooms of the 
participating centers or nearby public centers. 
2. Phase of increasing the number of daily steps 
(8 weeks, sessions of 60 minutes). The aim is to 
increase the number of daily steps performed by 
each of the subjects to reach 10,000 steps a day 
(or as close as possible taking into account the 
number of initial steps). The MHT nurse who heads 
the group will guide and teach different routes 
adapted to the physical condition of the subjects 
located in the vicinity of the recruitment centers. 
During the last week, the routes will be delivered 
on paper with recommendations and strategies to 
continue to maintain the total number of steps.
Dietary Intervention
There will be 2 sessions per week of 20 minutes 
duration for 8 consecutive weeks to provide basic 
knowledge about healthy dietary habits. 
They will be given by the nurses from the MHT 
or PCT centers in an entertaining and participatory 
manner. The nurses will record patient attendance 
in every session in order to assess the degree of 
compliance with the intervention. 
The proposed diet is a traditional Mediterranean 
diet for cardiovascular protection with low levels of 
fat and cholesterol, high in fiber and unsaturated 
fats and a reduction in salt intake to 5gr/day.
At the end of each session, any doubts that may 
have arisen will be clarified and a diary of food ea-
ten the last 24 hours will be looked over to review 
the knowledge acquired in each session.
Sessions 1 and 2. Content and objectives of the 
program and the importance of applying it to their 
daily lives. Proper diet. 
Sessions 3 and 4. Welfare. Ideal Weight and BMI
Sessions 5 and 6. Calculation of BMI. Obesity 
and diseases. 
Sessions 7 and 8. Care with overweight condi-
tion. Food pyramids.
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Sessions 9 and 10. Food Pyramid and portions. 
Nutritional requirements.
Sessions 11 and 12. Dietary Guidelines. Liquids.
Sessions 13 and 14. The making of a Mediterra-
nean diet. Eating Habits.
Sessions 15 and 16. Hygiene, preservation and 
preparation of food.
Outcomes
Primary outcomes
- Level of physical activity: the International 
Physical Activity questionnaire (IPAQ), adapted to 
Spanish, will be used [27]. It allows for the as-
sessment of PA as a continuous variable by calcu-
lating metabolic equivalent units [METs] per week 
and as a categorical variable, classifying subjects 
according to their level of PA (low, moderate or 
high). The IPAQ short form asks about three spe-
cific types of activity undertaken in the following 
domains: leisure time PA, domestic and gardening 
(yard) activities, work-related PA and transport-
related PA. The specific types of activity that are 
assessed are walking, moderate-intensity activities 
and vigorous-intensity activities. The items in the 
short IPAQ form were structured to provide se-
parate scores on each type of activity. Computa-
tion of the total score for the short form requires 
summation of the duration (in minutes) and fre-
quency (days) of walking, moderate-intensity and 
vigorous-intensity activities. Domain specific esti-
mates cannot be estimated. This questionnaire has 
shown good validity and reliability in the general 
population [23]. 
- Body mass index (BMI): It is calculated from 
the weight in kilos divided by the square of the 
height in meters (kg/m²). A scale and a wall stadio-
meter with the patient barefoot and upright will be 
used. From the quantitative variable, a categorical 
variable will be calculated, in accordance with the 
consensus of the Spanish Society for the Study of 
Obesity that separates normal weight (18,5-24,9), 
overweight (25-29,9) and obesity (>30) [10]. 
- Waist circumference: The measurement is 
made with a flexible tape parallel to the ground, 
uncompressed, at the midpoint between the last rib 
and the iliac crest. The reading is taken at the end 
of a normal exhalation. The observer is placed on 
one side of the person to be measured. The upper 
limits of 102 cm for men and 88 cm for women are 
accepted as normal [28].
Secondary outcomes
- Cardiovascular Risk: Calculation using REGI-
COR tables to determine the risk of a coronary 
event in 10 years. It takes into account sex and 
age as non-modifiable risk factors and, in addition, 
blood pressure and cholesterol, smoking status and 
the presence or not of diabetes [29]. 
- Quality of Life: With the SF36 questionnaire, 
an instrument developed from an extensive battery 
of questionnaires used in the Medical Outcomes 
Study [30]. It detects states of positive and negative 
health and explores physical and mental health. It 
consists of 36 items that explore eight dimensions 
of the health status. In validation studies [31], The 
Cronbach alpha coefficient was higher than 0.7 in 
all dimensions, and the intraclass correlation coeffi-
cient stood between 0.58 to 0.99. 
- Tobacco: Smoker (number of cigarettes/day)/
Ex-smoker (not smoked in the last year)/smoker up 
to less than 12 months ago/Non-Smoker.
- HDL cholesterol, LDL cholesterol, total cho-
lesterol, triglycerides, blood sugar: Units ex-
pressed in mg/100 ml. Collection method: venous 
puncture. A qualitative variable is calculated, with 
cutoffs of normality according to the ICS clinical prac-
tice guidelines, from each quantitative variable [32]. 
The initial analysis and follow-up will not be taken 
into account if there are any recorded in the last 
month. No analysis will be performed at six months.
- Blood pressure [BP]: Units expressed in mmHg. 
Measurement method according to the measure-
ment protocol. A qualitative variable is calculated 
good control/poor control [28].
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- Dietary Habits: Using the 14-item Medite-
rranean diet fulfillment questionnaire used in the 
PREDIMED study [33]. The score ranges from 0 to 
14 points, from minimum to maximum compliance. 
Consider 9 as the cutoff point [34].
Confounding variable
- Antipsychotic treatment prescribed to the 
patient: Active principle, dose, duration, therapeu-
tic group. History of antipsychotic treatment: thera-
peutic groups and duration of each drug.
- Chronic disease: Ischemic heart disease: I21-
I25; chronic obstructive pulmonary disease: J40-J44; 
Dyslipidemia: E78.0-E78.9; Hypertension: I10, I15; 
Diabetes mellitus: E10-E14; Asthma J45. Other re-
levant disease. The year of diagnosis will be noted. 
This information will be obtained through medical 
records and the clinical interview.
- Non-psychiatric active chronic medication: 
Recording of the active drugs (prescribed for at least 
6 months) and their drug therapy group. The date 
of the prescription's start will be recorded.
- Visited by a PCT professional during the stu-
dy period: number of visits
- Visited by a MHT professional during the 
study period: number of visits.
Variables related to the patient's mental state
- Brief Psychiatric Rating Scale, BPRS [35], de-
veloped to rapidly assess changes in the symptoms 
of patients with mental disorders. Actually, is one of 
the most frequently used instruments for evaluating 
psychopathology in patients with schizophrenia and 
in our setting is used as a measure of severity in 
these patients [36]. Validated in Spain in a version 
in the PANSS [37]. It consists of 18 items. It will be 
given to patients with schizophrenia or a schizoa-
ffective disorder.
- Clinical Global Impression Scale (Clinical Glo-
bal Impression, CGI) [38]. Applied scale that measu-
res the severity of symptoms and improvement of 
symptoms due to therapeutic interventions. There 
is a version for schizophrenia in Spanish: it consists 
of two scales of five items each. Each item is scored 
using a Likert scale from 1 (normal) to 7 (severely 
ill). There is also a version for patients with bipolar 
disorder [39] and it is validated in Castilian [25].
- Universal Variables: Age (date of birth), Sex 
(male or female), employment status (employed, 
unemployed, retired, disability, pensioner or hou-
sewife), educational level (illiterate, literate, primary 
school, secondary school, university), property type 
(family home, protected home, residence), the cen-
ter where the patient is recruited and where follow 
up is carried out during the study, the psychiatrist 
treating the patient (either public or private) and 
the GP and primary care team to which the patient 
is assigned.
Data collection and follow-up (Table 1)
 The evaluation of the response variable will be done 
blind at 0, 3, 6 and 12 months. At three months, 
the intervention ends and its immediate effect will 
be evaluated. At 6 months, the midterm results will 
be evaluated. At 12 months, the long-term results 
will be evaluated. 
Assessments will be conducted by evaluators 
(psychologists and mental health nurses) who do 
not participate in the intervention and are unaware 
of the group allocation of patients. 
Statistical analysis
There will be an analysis of intention to treat. All 
patients who signed the informed consent will be 
included as well as those who have done the initial 
assessment.
Descriptive statistics will be calculated for the 
dependent, confounding and general variables for 
both the IG and the CG . The homogeneity of 
the two groups for these variables at baseline will 
also be checked. 
In all cases, a bilateral alpha of 0.05 will be con-
sidered an error and confidence intervals will be 
calculated at 95%.
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An outcome variable will be calculated for each 
measurement point (3, 6 and 12 months) that is 
the difference between the result of BMI, WC and 
weekly amount of PA at each cutoff and the initial 
value for each individual. The differences between 
groups will be evaluated and the 95% confidence 
interval of the difference will be calculated.
An analysis of variance for repeated measures 
(ANOVA) to assess differences in the time of the 
dependent variables attributable to the effect of the 
intervention will be done. It will be adjusted for 
potential confounders: pharmacological treatment, 
care level of the intervention and the patient's men-
tal state.
Discussion
The increased mortality in patients with severe men-
tal illness is due in large part to the increased pre-
sence of cardiovascular risk factors. This study aims 
to demonstrate the effectiveness of a program of 
physical activity and diet coordinated between PCT 
and MHT to improve these factors. If the results 
are positive, their general level of implementation 
should be raised.
Throughout the implementation of the protocol, 
a number of limitations have been identified:
- Due to multicentrism of the study, centralized 
training of all participants in the study by the prin-
cipal investigator is necessary.
- Due to the inherent characteristics of these pa-
tients, recruitment may be slower than expected.
- It is a clinical trial in which professionals know 
the group to which the patient belongs. In any case, 
an effort will be made to preserve masking in some 
study milestones such as randomization, the eva-
luation of the primary measurements and statistical 
analysis of the data.
- The loss that can be generated in the moni-
toring may be high, it being long-term and under 
normal conditions. An effort will be made to ensure 
patient adherence through telephone locating (at 
least three attempts per appointment, if the patient 
has stated that they want to participate) when miss 
any scheduled visits and intervention sessions.
- There may be a possible contamination effect 
between patients in the same center but of very low 
intensity, because, in principle, the patients have no 
relation between them.
Table 1.  measurements taken at each follow-up 
point.
Data 
Collection
0 mths. 3 mths. 6 mrhs. 12 mths.
Questionnaire
socio-
demographic
X X X X
Physical Examination
Weight x x x x
Height x - - -
Waist 
Circumference
x x x x
Blood Pressure x x x x
Analysis
Total 
Colesterol, 
HDL, LDL, 
blood sugar y 
triglycerides
x x - x
Escalas
IPAQ x x x
Mediterranean 
Diet 
Adherence
x x x
BPRS x x x
CGI x x x
Clinical History Data
Drug 
Treatment
x x x x
Chronic 
Illnesses
x x x x
Visits to PCT x x x x
Visits to MHC x x x x
Hospital 
Admissions
x x x x
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- It affects physical activity and diet but not smo-
king because we believe that is another type of 
addiction (to drugs ...).
- The generalizability of the study may be dimi-
nished by the exclusion of patients dependent on 
substances other than nicotine. We have taken this 
decision because patients are recruited in mental 
health centers. In our setting, patients with psychia-
tric illness but with a high dependence on drug use 
are referred to other types of centers called welfare 
centers for drug addicts. The latter centers are not 
involved in the study.
Ethical aspects
All patients enrolled will be informed verbally and in 
writing of the objectives, methodology, tests and in-
terventions that they may receive if they participate 
in the study. Informed consent will be written in a 
language that the patient can understand. In case 
of disability, it must be signed by the legal guardian 
of the patient. Ethical aspects: the project has been 
evaluated and approved by the CEIC, the ethical 
committee of the Primary Healthcare-University Re-
search Institute IDIAP Jordi Gol, with registration 
number P11/64.
List of abreviations
Severe Mental Disorder (SMD)
Cardiovascular Risk Factors (CVRF)
Metabolic Syndrome (MS)
Body Mass Index (BMI)
Waist Circumference (WC)
Physical Activity (PA)
Primary Care Team (PCT) 
Mental Health Team (MHT)
Intervention Group (IG) 
Control Group (CG)
Metabolic Equivalent Units (METs)
Blood Pressure (BP)
Brief Psychiatric Rating Scale (BPRS)
Clinical Global Impression (CGI)
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